A new trading day began on Friday, with Reviva Pharmaceuticals Holdings Inc (NASDAQ: RVPH) stock price up 15.83% from the previous day of trading, before settling in for the closing price of $0.47. RVPH’s price has ranged from $0.30 to $4.28 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 40.00%. With a float of $60.81 million, this company’s outstanding shares have now reached $68.00 million.
The extent of productivity of a business whose workforce counts for 14 workers is very important to gauge. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Reviva Pharmaceuticals Holdings Inc (RVPH) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Reviva Pharmaceuticals Holdings Inc is 10.59%, while institutional ownership is 21.25%.
Reviva Pharmaceuticals Holdings Inc (RVPH) Performance Highlights and Predictions
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.25 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 40.00% per share during the next fiscal year.
Reviva Pharmaceuticals Holdings Inc (NASDAQ: RVPH) Trading Performance Indicators
Here are Reviva Pharmaceuticals Holdings Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.90.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.65, a number that is poised to hit -0.14 in the next quarter and is forecasted to reach -0.53 in one year’s time.
Technical Analysis of Reviva Pharmaceuticals Holdings Inc (RVPH)
The latest stats from [Reviva Pharmaceuticals Holdings Inc, RVPH] show that its last 5-days average volume of 4.1 million was superior to 1.69 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 71.92%.
During the past 100 days, Reviva Pharmaceuticals Holdings Inc’s (RVPH) raw stochastic average was set at 27.59%, which indicates a significant decrease from 58.35% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0467 in the past 14 days, which was lower than the 0.0737 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5174, while its 200-day Moving Average is $1.1093. Now, the first resistance to watch is $0.6260. This is followed by the second major resistance level at $0.7121. The third major resistance level sits at $0.7849. If the price goes on to break the first support level at $0.4671, it is likely to go to the next support level at $0.3943. Assuming the price breaks the second support level, the third support level stands at $0.3082.
Reviva Pharmaceuticals Holdings Inc (NASDAQ: RVPH) Key Stats
With a market capitalization of 36.72 million, the company has a total of 48,004K Shares Outstanding. Currently, annual sales are 0 K while annual income is -29,920 K. The company’s previous quarter sales were 0 K while its latest quarter income was -6,430 K.
